Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Agustí A[au]:

Search results

Items: 1 to 50 of 567

1.

When Harry Met Sally (or When Machine Learning Met COPD).

Agusti A, Faner R.

Am J Respir Crit Care Med. 2019 Nov 20. doi: 10.1164/rccm.201911-2123ED. [Epub ahead of print] No abstract available.

PMID:
31747303
2.

The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Int J Tuberc Lung Dis. 2019 Nov 1;23(11):1131-1141. doi: 10.5588/ijtld.19.0397.

PMID:
31718748
3.

COPD: Challenges and opportunities.

Agustí A.

Respirology. 2019 Oct 30. doi: 10.1111/resp.13723. [Epub ahead of print] No abstract available.

4.

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART.

Samperiz G, Fanjul F, Valera JL, Lopez M, Rios Á, Peñaranda M, Campins A, Riera M, Agusti A.

PLoS One. 2019 Oct 29;14(10):e0224510. doi: 10.1371/journal.pone.0224510. eCollection 2019.

5.

Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.

Criner GJ, Celli BR, Singh D, Agusti A, Papi A, Jison M, Makulova N, Shih VH, Brooks L, Barker P, Martin UJ, Newbold P.

Lancet Respir Med. 2019 Sep 27. pii: S2213-2600(19)30338-8. doi: 10.1016/S2213-2600(19)30338-8. [Epub ahead of print]

PMID:
31575508
6.

Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Agustí A, Hogg JC.

N Engl J Med. 2019 Sep 26;381(13):1248-1256. doi: 10.1056/NEJMra1900475. Review. No abstract available.

PMID:
31553836
7.

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States.

Iglesias-López C, Agustí A, Obach M, Vallano A.

Front Pharmacol. 2019 Aug 30;10:921. doi: 10.3389/fphar.2019.00921. eCollection 2019.

8.

Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?

Cuerpo S, Moisés J, Hernández-González F, Benegas M, Ramirez J, Sánchez M, Agustí À, Sellares J.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119869334. doi: 10.1177/1479973119869334.

9.

Clinical Fingerprinting: A Way to Address the Complexity and Heterogeneity of Bronchiectasis in Practice.

Martinez-Garcia MA, Aksamit TR, Agusti A.

Am J Respir Crit Care Med. 2019 Aug 5. doi: 10.1164/rccm.201903-0604PP. [Epub ahead of print]

PMID:
31381866
10.

UPSTAGING, CENTRALITY AND SURVIVAL IN EARLY STAGE NON-SMALL CELL LUNG CANCER VIDEO-ASSISTED SURGERY.

Boada M, Guzmán R, Montesinos M, Libreros A, Guirao A, Sánchez-Lorente D, Gimferrer JM, Agustí A, Molins L.

Lung Cancer. 2019 Aug;134:254-258. doi: 10.1016/j.lungcan.2019.06.030. Epub 2019 Jul 2.

PMID:
31319990
11.

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).

Cruz T, López-Giraldo A, Noell G, Casas-Recasens S, Garcia T, Molins L, Juan M, Fernandez MA, Agustí A, Faner R.

Respir Res. 2019 Jul 12;20(1):152. doi: 10.1186/s12931-019-1105-z.

12.

Heart and lungs in a single breath.

Washko GR, Agusti A.

Respirology. 2019 Oct;24(10):937-938. doi: 10.1111/resp.13641. Epub 2019 Jul 11. No abstract available.

13.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
14.

Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas.

Guirao A, Molins L, Ramón I, Sunyer G, Viñolas N, Marrades R, Sánchez D, Fibla JJ, Boada M, Hernández J, Guzmán R, Libreros A, Gómez-Caro A, Guerrero C, Agustí A.

Lung Cancer. 2019 Sep;135:230-233. doi: 10.1016/j.lungcan.2019.06.008. Epub 2019 Jun 15.

PMID:
31235316
15.

Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients.

Millares L, Pascual S, Montón C, García-Núñez M, Lalmolda C, Faner R, Casadevall C, Setó L, Capilla S, Moreno A, Castro-Acosta AA, Alvarez-Martinez CJ, Sibila O, Peces-Barba G, Cosio BG, Agustí A, Gea J, Monsó E.

BMC Pulm Med. 2019 Jun 24;19(1):112. doi: 10.1186/s12890-019-0867-x.

16.

It's more than low BMI: prevalence of cachexia and associated mortality in COPD.

McDonald MN, Wouters EFM, Rutten E, Casaburi R, Rennard SI, Lomas DA, Bamman M, Celli B, Agusti A, Tal-Singer R, Hersh CP, Dransfield M, Silverman EK.

Respir Res. 2019 May 22;20(1):100. doi: 10.1186/s12931-019-1073-3.

17.

Benralizumab for the Prevention of COPD Exacerbations.

Criner GJ, Celli BR, Brightling CE, Agusti A, Papi A, Singh D, Sin DD, Vogelmeier CF, Sciurba FC, Bafadhel M, Backer V, Kato M, Ramírez-Venegas A, Wei YF, Bjermer L, Shih VH, Jison M, O'Quinn S, Makulova N, Newbold P, Goldman M, Martin UJ; GALATHEA Study Investigators; TERRANOVA Study Investigators.

N Engl J Med. 2019 Sep 12;381(11):1023-1034. doi: 10.1056/NEJMoa1905248. Epub 2019 May 20.

PMID:
31112385
18.

Bronchiectasis: A Complex, Heterogeneous Disease.

Martínez-García MA, Olveira C, Máiz L, Girón RMª, Prados C, de la Rosa D, Blanco M, Agustí A.

Arch Bronconeumol. 2019 Aug;55(8):427-433. doi: 10.1016/j.arbres.2019.02.024. Epub 2019 Apr 18. English, Spanish.

19.

Global lung health: the dangers of mild lung function impairment.

Faner R, Agusti A.

Lancet Glob Health. 2019 May;7(5):e542-e543. doi: 10.1016/S2214-109X(19)30156-1. No abstract available.

20.

Precision medicine in obstructive sleep apnoea.

Martinez-Garcia MA, Campos-Rodriguez F, Barbé F, Gozal D, Agustí A.

Lancet Respir Med. 2019 May;7(5):456-464. doi: 10.1016/S2213-2600(19)30044-X. Epub 2019 Apr 12. Review. Erratum in: Lancet Respir Med. 2019 Oct;7(10):e32.

PMID:
30987857
21.

Smoking Impairs the Immunomodulatory Capacity of Lung-Resident Mesenchymal Stem Cells in Chronic Obstructive Pulmonary Disease.

Cruz T, López-Giraldo A, Noell G, Guirao A, Casas-Recasens S, Garcia T, Saco A, Sellares J, Agustí A, Faner R.

Am J Respir Cell Mol Biol. 2019 Nov;61(5):575-583. doi: 10.1165/rcmb.2018-0351OC.

PMID:
30978114
22.

Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration.

Agusti A, Faner R, Donaldson G, Heuvelin E, Breyer-Kohansal R, Melén E, Maitland-van der Zee AH, Vestbo J, Allinson JP, Vanfleteren LEGW, van den Berge M, Adcock IM, Lahousse L, Brusselle G, Wedzicha JA; on behalf of the CADSET Clinical Research Collaboration; Current members of the CADSET Clinical Research Collaboration.

Eur Respir J. 2019 Mar 18;53(3). pii: 1900217. doi: 10.1183/13993003.00217-2019. Print 2019 Mar. No abstract available.

PMID:
30886026
23.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
24.

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG; participants of the Treatable Traits Down Under International Workshop; Treatable Traits Down Under International Workshop participants:.

Eur Respir J. 2019 May 9;53(5). pii: 1802058. doi: 10.1183/13993003.02058-2018. Print 2019 May. Review.

PMID:
30846468
25.

Lung function trajectories in health and disease.

Agusti A, Faner R.

Lancet Respir Med. 2019 Apr;7(4):358-364. doi: 10.1016/S2213-2600(18)30529-0. Epub 2019 Feb 11. Review.

PMID:
30765254
26.

Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Washko GR, Nardelli P, Ash SY, Vegas Sanchez-Ferrero G, Rahaghi FN, Come CE, Dransfield MT, Kalhan R, Han MK, Bhatt SP, Wells JM, Aaron CP, Diaz AA, Ross JC, Cuttica MJ, Labaki WW, Querejeta Roca G, Shah AM, Young K, Kinney GL, Hokanson JE, Agustí A, San José Estépar R.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461. doi: 10.1164/rccm.201811-2063OC.

PMID:
30758975
27.

Prospective observational study in patients with obstructive lung disease: NOVELTY design.

Reddel HK, Gerhardsson de Verdier M, Agustí A, Anderson G, Beasley R, Bel EH, Janson C, Make B, Martin RJ, Pavord I, Price D, Keen C, Gardev A, Rennard S, Sveréus A, Bansal AT, Brannman L, Karlsson N, Nuevo J, Nyberg F, Young SS, Vestbo J.

ERJ Open Res. 2019 Feb 1;5(1). pii: 00036-2018. doi: 10.1183/23120541.00036-2018. eCollection 2019 Feb.

28.

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease.

Jiménez D, Agustí A, Monreal M, Otero R, Huisman MV, Lobo JL, Quezada A, Jara-Palomares L, Hernando A, Tabernero E, Marcos P, Ruiz-Artacho P, Ballaz A, Bertoletti L, Couturaud F, Yusen R; SLICE investigators.

Clin Cardiol. 2019 Mar;42(3):346-351. doi: 10.1002/clc.23161. Epub 2019 Feb 25.

29.

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis.

Faner R, Morrow JD, Casas-Recasens S, Cloonan SM, Noell G, López-Giraldo A, Tal-Singer R, Miller BE, Silverman EK, Agustí A, Hersh CP.

Respir Res. 2019 Jan 8;20(1):5. doi: 10.1186/s12931-018-0965-y.

30.

Development of a pharmaceutical care program in progressive stages in geriatric institutions.

Mestres C, Hernandez M, Agustí A, Puerta L, Llagostera B, Amorós P.

BMC Geriatr. 2018 Dec 19;18(1):316. doi: 10.1186/s12877-018-1002-1.

31.

Early Life Origins of Asthma: A Review of Potential Effectors.

Bobolea I, Arismendi E, Valero A, Agustí A.

J Investig Allergol Clin Immunol. 2019;29(3):168-179. doi: 10.18176/jiaci.0361. Epub 2018 Dec 18. Review.

32.

Are semantic and episodic autobiographical memories influenced by the life period remembered? Comparison of young and older adults.

Meléndez JC, Agusti AI, Satorres E, Pitarque A.

Eur J Ageing. 2018 Jan 19;15(4):417-424. doi: 10.1007/s10433-018-0457-4. eCollection 2018 Dec.

33.

Physical Activity Is Associated with Attenuated Disease Progression in Chronic Obstructive Pulmonary Disease.

Demeyer H, Donaire-Gonzalez D, Gimeno-Santos E, Ramon MA, DE Battle J, Benet M, Serra I, Guerra S, Farrero E, Rodriguez E, Ferrer J, Sauleda J, Monso E, Gea J, Rodriguez-Roisin R, Agusti A, Antó JM, Garcia-Aymerich J.

Med Sci Sports Exerc. 2019 May;51(5):833-840. doi: 10.1249/MSS.0000000000001859.

PMID:
30531289
34.

Heterogeneity and complexity in bronchiectasis: A pending challenge.

Martinez-Garcia MA, Agustí A.

Arch Bronconeumol. 2019 Apr;55(4):187-188. doi: 10.1016/j.arbres.2018.09.010. Epub 2018 Nov 22. English, Spanish. No abstract available.

35.

Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case-Control Study with Follow-up.

Borràs-Santos A, Garcia-Aymerich J, Soler-Cataluña JJ, Vigil Giménez L, Gea Guiral J, Rodríguez Chiaradía D, Pascual-Guardia S, Marcos Rodríguez PJ, Alvarez Martinez CJ, Casanova Macario C, López-Campos JL, Carrasco Hernández L, Martínez-González C, Santos-Pérez S, Peces-Barba G, Molina Paris J, Román Rodríguez M, Barberà JA, Faner R, Agustí A, Cosío BG; en representación del Grupo Investigador del estudio EARLY COPD.

Arch Bronconeumol. 2019 Jun;55(6):312-318. doi: 10.1016/j.arbres.2018.09.007. Epub 2018 Nov 11. English, Spanish.

36.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
37.

Do we really need a new classification of airway diseases?

Agusti A, Pavord ID.

Lancet Respir Med. 2018 Dec;6(12):891-893. doi: 10.1016/S2213-2600(18)30386-2. Epub 2018 Nov 9. No abstract available.

PMID:
30420248
38.

Lessons from a Life: The Manuel Tapia Lecture 2018.

Agusti A.

Arch Bronconeumol. 2019 Mar;55(3):177-180. doi: 10.1016/j.arbres.2018.09.003. Epub 2018 Nov 2. English, Spanish. No abstract available.

39.

The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study.

Breyer-Kohansal R, Hartl S, Burghuber OC, Urban M, Schrott A, Agusti A, Sigsgaard T, Vogelmeier C, Wouters E, Studnicka M, Breyer MK.

J Epidemiol. 2019 Aug 5;29(8):315-324. doi: 10.2188/jea.JE20180039. Epub 2018 Oct 20.

40.

The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.

Gea J, Pascual S, Castro-Acosta A, Hernández-Carcereny C, Castelo R, Márquez-Martín E, Montón C, Palou A, Faner R, Furlong LI, Seijo L, Sanz F, Torà M, Vilaplana C, Casadevall C, López-Campos JL, Monsó E, Peces-Barba G, Cosío BG, Agustí A; en representación del grupo BIOMEPOC; Anexo. Miembros del grupo BIOMEPOC.

Arch Bronconeumol. 2019 Feb;55(2):93-99. doi: 10.1016/j.arbres.2018.07.026. Epub 2018 Oct 19. English, Spanish.

41.

INTEND II randomized clinical trial of intraoperative duct endoscopy in pathological nipple discharge.

Gui G, Agusti A, Twelves D, Tang S, Kabir M, Montgomery C, Nerurkar A, Osin P, Isacke C.

Br J Surg. 2018 Nov;105(12):1583-1590. doi: 10.1002/bjs.10990. Epub 2018 Sep 20.

PMID:
30238438
42.

Inhaled corticosteroids in COPD: friend or foe?

Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FME, Rabe KF, Papi A.

Eur Respir J. 2018 Dec 13;52(6). pii: 1801219. doi: 10.1183/13993003.01219-2018. Print 2018 Dec. Review.

PMID:
30190269
43.

Treatable traits in bronchiectasis.

Boaventura R, Sibila O, Agusti A, Chalmers JD.

Eur Respir J. 2018 Sep 6;52(3). pii: 1801269. doi: 10.1183/13993003.01269-2018. Print 2018 Sep. No abstract available.

PMID:
30190263
44.

The Overlap of Lung Tissue Transcriptome of Smoke Exposed Mice with Human Smoking and COPD.

Obeidat M, Dvorkin-Gheva A, Li X, Bossé Y, Brandsma CA, Nickle DC, Hansbro PM, Faner R, Agusti A, Paré PD, Stampfli MR, Sin DD.

Sci Rep. 2018 Aug 8;8(1):11881. doi: 10.1038/s41598-018-30313-z.

45.

Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study.

Adir Y, Hakrush O, Shteinberg M, Schneer S, Agusti A.

ERJ Open Res. 2018 Aug 3;4(3). pii: 00022-2018. doi: 10.1183/23120541.00022-2018. eCollection 2018 Jul.

46.

The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model.

Ramon MA, Ter Riet G, Carsin AE, Gimeno-Santos E, Agustí A, Antó JM, Donaire-Gonzalez D, Ferrer J, Rodríguez E, Rodriguez-Roisin R, Puhan MA, Garcia-Aymerich J; PAC-COPD Study Group.

Eur Respir J. 2018 Sep 15;52(3). pii: 1800079. doi: 10.1183/13993003.00079-2018. Print 2018 Sep.

PMID:
30072504
47.

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD.

López-Giraldo A, Cruz T, Molins L, Guirao Á, Saco A, Cuerpo S, Ramirez J, Agustí Á, Faner R.

BMC Pulm Med. 2018 Jul 31;18(1):123. doi: 10.1186/s12890-018-0688-3.

48.

Whole exome sequencing analysis in severe chronic obstructive pulmonary disease.

Qiao D, Ameli A, Prokopenko D, Chen H, Kho AT, Parker MM, Morrow J, Hobbs BD, Liu Y, Beaty TH, Crapo JD, Barnes KC, Nickerson DA, Bamshad M, Hersh CP, Lomas DA, Agusti A, Make BJ, Calverley PMA, Donner CF, Wouters EF, Vestbo J, Paré PD, Levy RD, Rennard SI, Tal-Singer R, Spitz MR, Sharma A, Ruczinski I, Lange C, Silverman EK, Cho MH.

Hum Mol Genet. 2018 Nov 1;27(21):3801-3812. doi: 10.1093/hmg/ddy269.

49.

Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.

Faner R, Noell G, Badia JR, López-Giraldo A, Bakke P, Silverman EK, Tal-Singer R, Agustí A.

Respir Med. 2018 Aug;141:14-19. doi: 10.1016/j.rmed.2018.06.015. Epub 2018 Jun 19.

PMID:
30053959
50.

Precision medicine in COPD exacerbations.

Agusti A, Faner R, Celli B, Rodriguez-Roisin R.

Lancet Respir Med. 2018 Sep;6(9):657-659. doi: 10.1016/S2213-2600(18)30296-0. Epub 2018 Jul 18. No abstract available.

PMID:
30029970

Supplemental Content

Loading ...
Support Center